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I. INTRODUCTION
Over the past few years, the stem cell debate has grown heated, becoming one of
the most controversial topics addressed in the United States today. However, the
current debate, centering primarily on embryonic stem cells, neglects to recognize
and address the significance of a different type of stem cell that is less controversial
and is already being used to treat and cure a variety of diseases.1 Stem cells located
in the blood of the umbilical cord of a newly delivered infant can be easily and
painlessly harvested from the cord2 and then donated by the mother to a public or
private bank for future use in treating the diseases of matching recipients.3 More
specifically, cord blood stem cells can be transplanted into individuals suffering from
certain cancers or blood disorders as a way to treat and cure their condition.4
1
Courtney Witte, Commentary, Cord Blood Storage Property and Liability Issues, 26 J.
LEGAL MED. 275, 277 (2005). “The California Catholic Conference states that cord blood is a
non-controversial and ethical supply of stem cells…[that] provides a more effective transplant
source than bone marrow at one third the cost.” Dale Orthner, Chapter 484: Informing
Expectant Mothers About Umbilical Cord Blood Banking, 38 MCGEORGE L. REV. 205, 212
(2007).
2

Witte, supra note 1, at 276-77.

3

Orthner, supra note 1, at 206.

4

Joanne Kurtzberg et al., Untying the Gordian Knot: Policies, Practices, and Ethical
Issues Related to Banking of Umbilical Cord Blood, 115 J. CLIN. INVEST. 2592, 2593, 2596
(2005).
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Although these stem cells have significant medical potential, lack of awareness
of donation and failure to provide donation services result in missed donation
opportunities.5 While there is legislation at both the federal and state levels
encouraging information to be provided to expecting mothers as a means to increase
donation, such legislation falls below that necessary to truly promote and increase
donations.6 Current legislation, including Ohio’s proposed legislation, Ohio House
Bill 237 (“OH H.B. 237”) tends to encourage, rather than require, that information
about cord blood donation be provided, and there is no requirement that donation
services be made available to each patient.7 Because there are no assurances that
information and donation services will actually be provided to pregnant women, the
legislation cannot realistically improve the number of donations.
Because current legislation, including OH H.B. 237, is insufficient in that it does
not have the potential to significantly increase the number of cord blood donations, it
will be necessary to enact legislation that is more demanding. Such legislation
should be modeled after current “required request” organ donation laws, which
mandate that health professionals actively pursue organ donations by expressly
asking the family to consent to donation.8 Modeled after these laws, better
legislation will not only require that state health departments generate information
about donation opportunities, but also that health professionals then provide each
maternity patient with materials about cord blood donation and, if desired, donation
services.
This note will discuss the use and donation of umbilical cord blood stem cells
and explore the insufficiency of current legislation intended to promote public
donation. Part II will provide an explanation of stem cells and umbilical cord blood
stem cells and will discuss the specific use of umbilical cord blood stem cells to treat
different diseases. Part III will discuss the collection and storage of umbilical cord
blood stem cells. Part IV will address the history of cord blood transplants and the
current demand for donations. Part V will discuss the current proposed and enacted
legislation regarding umbilical cord blood stem cell awareness and donation at the
federal and state levels. Part VI will discuss OH H.B. 237, explaining both the
content of the proposed legislation and its shortcomings. Part VII will focus on
current organ donation laws, detailing the transition in the United States from
encouraged voluntarism to routine inquiry and required request. Finally, Part VIII
will detail a more appropriate, sufficient piece of legislation, modeled after the
required request laws, which Ohio should adopt in lieu of OH H.B. 237.
5

Orthner, supra note 1, at 212.

6

See, e.g., CAL. HEALTH & SAFETY CODE §123371 (West 2008), amended by 2007 Cal.
Legis. Serv. Ch. 517 (S.B. 962) (West) (explaining that information about the option to donate
umbilical cord blood be generated, but not requiring that the information be provided to each
pregnant patient). While Congress has allocated funds to create a national cord blood stem
cell bank network, little has been done to raise awareness. As a result, pregnant women are
often unaware of the option to donate their infant’s umbilical cord blood to either a public or
private bank. Caroline P. Torrisi, Embryonic vs. Adult: The History and Future of the Stem
Cell Debate, 3 J. HEALTH & BIOMED. L. 143, 161 (2007).
7
8

H.B. 237, 127th Gen. Assembl., Reg. Sess. (Ohio 2007).

Melissa N. Kurnit, Organ Donation in the United States: Can We Learn From Success
Abroad? 17 B.C. INT’L & COMP. L. REV. 405, 412 (1994).
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II. STEM CELLS
Stem cells are cells within the human body that have the potential to develop into
many different cell types.9 Because stem cells have the ability to develop into other
types of cells, they are able to serve as a sort of repair system for the body,
developing without limit to replenish other cells that have been damaged or no
longer function as a result of disease.10 Scientists can work with stem cells in the lab
and engineer them to become a specific type of tissue, cell, or organ to be used in
transplantation or treatment of specific diseases.11
Human stem cells can be totipotent, pluripotent, or multipotent.12 Totipotent
cells give rise to all the different types of cells in the body and therefore have the
potential to develop into a fully formed human being.13 Totipotent cells, which are
found in fertilized human eggs, “are created at fertilization and are present for four
days immediately following conception, after which they become pluripotent
cells.”14 Pluripotent cells are able to give rise to any type of cell in the body except
those needed to develop a fetus, and are found in human embryos and fetal tissue.15
Multipotent stem cells are only able to give rise to a smaller, limited number of
different cell types.16 Because totipotent and pluripotent stem cells have the potential
to develop into a greater number of different cell types, they have greater therapeutic
potential.17 More specifically, pluripotent stem cells may have the potential to
create replacement cells and tissues to treat diseases and conditions including

9
The National Institute of Health, Stem Cell Information: Frequently Asked Questions,
http://stemcells.nih.gov/info/faqs.asp (last visited November 18, 2007) [hereinafter NIH]. All
stem cells have the ability to divide and renew themselves indefinitely. Torrisi, supra note 6,
at 144. Although they are unspecialized, meaning that they do not belong to any specific
tissue structure that would cause them to form a specialized function, they can, through
differentiation, develop into specialized cells. Id.
10

NIH, supra note 9.

11

Id.

12

Torrisi, supra note 6, at 144.

13

Id. Because they have the potential to develop into a fully formed human being, the use
of totipotent cells, like pluripotent cells, has met with strong ethical objections. Id.
14

Id.

15

NIH, supra note 9.

16

Id. Multipotent cells can only develop into cells with the same tissue or organ. So, for
example, multipotent blood cells are only able to develop into other types of blood cells, and
cannot, therefore, develop into brain cells. Torrisi, supra note 6, at 145.
17

NIH, supra note 9. “Plasticity” is a term used to refer to a cell’s ability to develop into
more than one type of cell. Pluripotent stem cells, like those extracted from embryos, have a
higher plasticity than multipotent adult stem cells. In addition to having greater plasticity,
pluripotent embryonic stem cells multiply at a faster rate than multipotent adult stem cells.
Rebekah L. Bailey, Pressing Forward: Connecticut’s Approach to Embryonic Stem Cell
Research, 26 L. & INEQ. 133, 138 (2008).
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Parkinson’s and Alzheimer’s diseases, spinal cord injury, stroke, burns, heart
disease, diabetes, osteoarthritis, and rheumatoid arthritis.18
Embryonic stem cells, which are pluripotent stem cells extracted from human
embryos, “are derived from a cluster of cells called the inner cell mass of the
blastocyst, located within a fertilized egg.”19 The cluster of cells from which the
stem cells are taken exist only throughout the first few days of development.20 If the
cells are extracted within those first few days before the cells begin to differentiate,
they can be kept as undifferentiated stem cells, retaining their potential to develop
into any type of cell.21 However, because removing the cluster of cells from the
blastocyst destroys the embryo, widespread ethical concerns over the use and
destruction of human embryos arises.22

18

NIH, supra note 9. Because embryonic stem cells have the potential to cure such a wide
variety of diseases afflicting numerous Americans, many scientists, academics, politicians, and
other well known individuals have joined in the heated debate, publicly announcing their
support for embryonic stem cell research. Actor Michael J. Fox, for example, has become a
public advocate for embryonic stem cell research, explaining, “[t]his is big. This is not a
wedge issue…This is…who we are as a country and how we feel about our people and about
the majority…respecting the minority. If the potential of stem cell research is realized, it
would mean an end to the suffering of millions of people—a rescue, a cure…Stem cells could
lead to breakthroughs in developing treatments and cures for almost any terminal or
catastrophic disease you can think of. This is one of the reasons that support for this work has
galvanized a coalition of advocates from just about every patient community in the nation. If
stem cell research succeeds, there isn’t a person in the country who won’t benefit, or know
somebody who will.” Bailey, supra note 17, at 133. Professor Cibelli, head of the Cellular
Reprogramming Laboratory at Michigan State University, has echoed some of these
sentiments, exclaiming, “[W]ake up America! This is not about Republican vs. Democrat,
pro-life vs. pro-choice, scientists vs. intellectuals, embryonic stem cells vs. adult stem cells. It
is about compassion for those suffering. It is about millions of patients around the world that
deserve better quality of life.” Id. at 169.
19

Torrisi, supra note 6, at 145. Stem cells were first successfully isolated from mouse
embryos in 1981. In 1998, two different groups of scientists were able to isolate human
embryonic stem cells. Dr. John Gearhart of Johns Hopkins University, along with his team of
researchers, extracted embryonic germ cells from an aborted fetus. Dr. James Thompson of
the University of Wisconsin-Madison, along with his research team, extracted stem cells from
an embryo obtained from an in vitro fertilization clinic. Bailey, supra note 17, at 135-36.
20

Torrisi, supra note 6, at 145.

21

Id. at 146. If the blastocyst successfully attaches to the uterus, it will begin to multiply
and differentiate, eventually forming a human fetus, placenta, and umbilical cord. However,
about seventy-five percent of blastocysts never attach to become fetuses. In some instances
more than one blastocyst will attach, which could cause multiple fetuses, but it is also likely
that some of the attached blastocysts will be dissolved or subsumed into the surviving embryo.
Bailey, supra note 17, at 136.
22

Torrisi, supra note 6, at 143. Not all of the cells in the blastocyst continue to form a
fetus; some will develop into the placenta or umbilical cord. As a result, some scientists prefer
to label the cells of the blastocyst at this point in development as “preimplantation” embryos
or “prembryos.” Bailey, supra note 17, at 136.
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Federal funding for the use and development of embryonic stem cells is limited23
as a result of these ethical concerns.24 Throughout the 1980’s, both former
Presidents Reagan and Bush Sr. strongly opposed embryonic stem cell research.25
Former President Clinton, however, was supportive, and after his election in 1994 he
lifted the long-standing ban on federal funding of embryonic stem cell research.26
The National Institute of Health (“NIH”), however, was still unable to gain the
approval of Congress for federal funding of embryonic stem cell research.27 In 2000
the NIH Guidelines were released, which encouraged federal funding for research
done on embryonic stem cells that were originally created for the purposes of fertility
treatment,28 but rejected federal funding for research done on cells created solely for
research purposes.29 However, President Bush rejected these guidelines in 2001

23

Torrisi, supra note 6, at 160.

24

See generally Bailey, supra note 17, at 140. Bailey points out that opponents of
embryonic stem cell research have analogized the destruction of embryos in the research to
abortion. Bailey suggests that this analogy is inappropriate, however, and that the effect of the
pro-life movement on embryonic stem cell research is tragic because of the selectivity of
prohibition against embryonic and fetal destruction. She explains that while opponents
analogize stem cell research to the termination of developed fetuses, embryonic stem cell
research laws are rarely applied to alternative reproduction technologies, and points out that,
although in vitro fertilization involves the destruction of embryos at a similar stage of
development as done with embryonic stem cells, in vitro fertilization practices enjoy much
more limited restrictions than stem cell research.
25

Id. at 156.

26
Id. Former President Clinton continued to endorse his position, giving a speech in 2000
that advocated embryonic stem cell research. In the speech Clinton stated, “[W]e cannot walk
away from the potential to save lives and to improve lives, to help people literally to get up
and walk, to do all kinds of things we could never have imagined, as long as we meet rigorous
ethical standards.” Bailey, supra note 17, at 145-46.
27

Torrisi, supra note 6, at 156.

28

Id. at 157. In vitro fertilization treatments, which were developed in the late 1970’s,
entail the creation of an embryo by joining a sperm and egg in the laboratory, which is then
inserted into the woman’s womb with hopes of causing impregnation. Bailey, supra note 17,
at 140. Because the chances of implantation using in vitro fertilization techniques are low,
several embryos are injected with each treatment, and often many more embryos are created
than are needed or will actually be used. Id. at 140-41. There are several options regarding
what to do with the excess embryos. Id. at 141. The embryos can be destroyed, donated to
other couples, donated to research, or suspended in cryopreservation, that is, frozen so that the
cells do not continue to multiply. Id. Cryopreservation is done either to save the embryos for
future use or to halt cell growth until a final decision is made. Id.
29

Torrisi, supra note 6, at 157-58. The guidelines state that in order to receive federal
funding for embryonic stem cell research, the cells used must have come from a fertility clinic,
the cells must be in excess of clinical need, there must have been a clear separation between
the decision to create the embryos for fertility treatment and the decision to donate them for
research, the cells must have been obtained with the informed consent of the fertility patient,
and there must have been no inducement offered to the patient for the donation of the
embryos. Bailey, supra note 17, at 145.
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when he announced his decision on federal funding for embryonic stem cell
research.30
President Bush’s policy allows federal funding for research on cell lines that have
already been developed from embryonic stem cells, but does not allow funding for
the creation of additional cell lines.31 More specifically, the policy limits funding to
stem cells that were removed from the embryo before August 9, 2001, the date on
which the President outlined the policy.32 Furthermore, the embryo must have been
created for reproductive purposes but no longer needed, and the embryo itself must
no longer have the possibility of developing into a human being.33 “Because many
academic researchers rely on federal funds to support their laboratories,” such a
limitation on research funding results in tremendous focus on embryonic stem cell
research.34

30

Torrisi, supra note 6, at 158. In addition to the federal policy, some states have chosen
to enact even more stringent limitations on embryonic stem cell research. For example,
Louisiana has enacted a statute which defines an embryo as a “judicial person” deserving of
human rights until it is implanted in the uterus or fails to develop outside of cryopreservation
within thirty-six hours. The statute declares that the use of an embryo in in vitro fertilization
is to be “solely for the support and contribution of the complete development of human in
utero implantation.” Thus, unwanted frozen embryos are only available for adoption by other
couples, and cannot be used for research purposes. While Louisiana has the most restrictive
statute, other states have adopted similar legislation prohibiting embryonic stem cell research
and attributing some level of life to human embryos. On the other hand, other states have
specifically endorsed embryonic stem cell research, proposing the allocation and disbursement
of state funds for embryonic experimentation and research. For example, Maryland, in 2007,
began disbursing fifteen million dollars in state funding to stem cell research, while New York
planned on disbursing two billion dollars over the course of ten years. Connecticut enacted
legislation in June 2005 which allocated one hundred million dollars of state funds over ten
years to stem cell research and also created state regulations for both privately and publicly
funded experimentation. California adopted legislation in 2002 that declared stem cell
research a state constitutional right, allocating three billion dollars over ten years to research,
giving priority to embryonic stem cell research. Other states have allowed funding for the
construction of experimentation and research facilities, but stop short of providing funds for
embryonic stem cell research itself. For example, New Jersey recently considered providing
two hundred million dollars of state funding to the construction of three new research
facilities. Illinois has decided to allocate ten million dollars to establish facilities and
Wisconsin has developed similar plans as well. Bailey, supra note 17, at 150-53.
31
Torrisi, supra note 6, at 159. By allowing research to be done on already existing stem
cell lines, but refusing to allow the creation of additional lines, President Bush’s policy was
meant to be a compromise. Id. at 157-59.
32

NIH, supra note 9.

33

Id. President Bush’s policy also denies funding for facilities or equipment that would be
used to conduct unauthorized embryonic stem cell research. Bailey, supra note 17, at 146.
34

NIH, supra note 9. Because the federal regulations apply only to publicly funded
clinics, privately funded laboratories are still able to conduct research on embryonic stem
cells. Torrisi, supra note 6, at 160. Private endowments at universities including Stanford, the
University of Wisconsin-Madison, the University of Minnesota, the University of California,
San Francisco, and Harvard have been established to support embryonic stem cell research.
However, generous private sources cannot adequately substitute for federal grants because of
the substantial cost of research. Bailey, supra note 17, at 146. Consequently, the inability of
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When President Bush’s policy was announced in 2001, there were approximately
60 stem cell lines already in existence that met the federally mandated criteria and
were available for research.35 Since then, many of these lines have been damaged or
have died, and as of March 2007, there were only 21 available lines,36 leaving
scientists limited to an even smaller number of cell lines.37 To alleviate this problem,
Congress passed The Stem Cell Research Enhancement Act of 2005, which allows
federal funding for research done on stem cells harvested from surplus embryos
created in fertility clinics.38 Even though most of the surplus cells would be
discarded if not used for research, President Bush vetoed the legislation, stating that
he would not force taxpayers to “fund the deliberate destruction of human
embryos.”39 The House of Representatives passed the legislation again in 2007, but
did not have enough votes to overcome the President’s promised veto.40
Although embryonic stem cells have great medical potential, by focusing solely
on embryonic stem cells, the current debate neglects a highly significant source of
similarly valuable, but different, stem cells.41 Certain types of multipotent bloodpublicly funded clinics to contribute to embryonic stem cell research prevents the research as a
whole from reaching its full potential. Torrisi, supra note 6, at 160. See also Bailey, supra
note 17, at 134 (stating that the federal policy “has severely hindered the progress of American
scientists, dashing the hopes of millions who await cures for their debilitating diseases and
injuries”).
35

Torrisi, supra note 6, at 158.

36

See Bailey, supra note 17, at 149 (arguing that the number of available cell lines seems
insignificant when considering the fact that, as of 2003, there were 400,000 unused frozen
embryos within the United States).
37

Scientists have discovered a problem regarding the existing cell lines, which further
hampers embryonic stem cell research. Mouse feeder cells excrete certain chemicals that keep
the cells from differentiating and have been used on the existing cell lines as a way to maintain
them for future use. However, because use of mouse feeder cells on the cell lines may leave
the stem cells vulnerable to potential viral infections that can remain undetected for many
years, the use of such feeder cells may have caused contamination of some of the existing cell
lines. Although researchers in Singapore have developed a technique to preserve cell lines
without having to use mouse feeder cells, the damage has already been done to the existing
cell lines available in the U.S. Bailey, supra note 17, at 149-50.
38
Torrisi, supra note 6, at 159. It was a Republican-led Congress that in 2005 passed the
Act in an attempt to reject President Bush’s policy. Bailey, supra note 17, at 147.
39

Torrisi, supra note 6, at 159.

40
Id. at 159-60. President Bush’s policy has been attacked by both research advocates and
anti-research advocates. Research advocates point to the fact that unused embryos continue to
be discarded at fertilization clinics, arguing that the 2001 distinction is arbitrary. Antiresearch advocates state that the policy only restricts federal funding of research and says little
about experimentation funded by private sources; thus, they argue, allowing experimentation
on any embryos improperly validates embryonic stem cell research. Bailey, supra note 17, at
148.
41

The General Assembly of Arkansas made legislative findings in regards to its legislation
dealing with cord blood donation, explaining that stem cell research has been hampered by the
controversy over the use of embryonic stem cells, and that umbilical cord blood stem cells
may be used for scientific research and medical treatment without destroying embryos. ARK.
CODE ANN. § 20-8-502 (West 2007). Furthermore, although studies are not conclusive as to
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forming stem cells known as hematopoietic stem cells are currently being used to
treat human diseases.42 These stem cells, found in bone marrow and umbilical cord
blood,43 are being transplanted to treat more than 75 life-threatening diseases,
including several types of cancer, bone marrow failure syndromes, blood disorders,
and immunodeficiencies.44 Patients with these diseases are ill because normal cells
of the blood system are not functioning correctly.45 The hematopoietic stem cells
found in cord blood are self-perpetuating and can give rise to mature cell types.46
When these cells are transplanted into the ill recipient, they begin to generate healthy
cells and tissues.47 More specifically, after these hematopoietic stem cells are
transferred into the ill patient, the stem cells, which will reside in the bone marrow of

whether the adult stem cells found in cord blood have as great a potential as embryonic stem
cells, recent studies have shown that these stem cells are far more useful than previously
believed. Torrisi, supra note 6, at 160. In some studies, cord blood has been shown to
transdifferentiate to a limited extent into some nonhematopoietic cells, including brain, heart,
liver, pancreas, bone, and cartilage cells; although purely speculative at this point, these
studies suggest the possibility that cord blood may serve, in the future, as a source of cells to
facilitate tissue repair and regeneration. Kurtzberg, supra note 4, at 2596.
42

NIH, supra note 9. The American Academy of Pediatrics has found the use of umbilical
cord blood to be effective in treating certain types of leukemia, lymphomas, aplastic anemia
and other cytopenias, immune deficiencies, hemoglobinopathies, thalassemia, and sickle cell
anemia. American Academy of Pediatrics, Work Group on Cord Blood Banking, Cord Blood
Banking for Potential Future Transplantation: Subject Review, 104 PEDIATRICS 116, 117
(1999)[hereinafter A.A.P.]. Furthermore, because umbilical cord blood stem cells are
removed from the human body after birth, their use does not raise the ethical concerns created
by the use of embryonic stem cells. Torrisi, supra note 6, at 160.
43

Sheila R. Kirschenbaum, Banking on Discord: Property Conflicts in the Transplantation
of Umbilical Cord Stem Cells, 39 ARIZ. L. REV. 1391, 1392 (1997). About one in every 10,000
to 15,000 bone marrow cells is thought to be a stem cell. In the blood stream, about one in
every 100,000 blood cells is a stem cell. Doctors are able to extract stem cells to be used in
transplants from peripheral, circulating blood. The National Institute of Health, Stem Cell
Information: Hematopoietic Stem Cells, http://stemcells.nih.gov/info/scireport/chapter5.asp
(last visited November 18, 2007)[hereinafter NIH].
44

Witte, supra note 1, at 277. The first evidence of the capabilities of blood-forming stem
cells came from studies in 1945 of people exposed to lethal doses of radiation. In the early
1960’s scientists began researching and analyzing bone marrow to find out which components
were responsible for generating blood. These studies culminated in researchers defining two
significant characteristics of hematopoietic stem cells, which are their ability to renew
themselves and produce cells that give rise to all the different types of blood cells. Since the
1960’s, research has focused on identifying these cells, which is difficult to do because
hematopoietic stem cells look and behave like ordinary white blood cells. NIH, supra note 43.
45

Kirschenbaum, supra note 43, at 1393.

46

Id.

47

Id. at 1393-94. After chemotherapy or radiation is used to destroy malignant cells in
patients suffering from cancer, as a result of which the patient’s immune system is severely
compromised, cord blood stem cells can be used to help restore the immune system. Stephen
R. Munzer, The Special Case of Property Rights in Umbilical Cord Blood for Transplantation,
51 RUTGERS L. REV. 493, 502 (1999).
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the patient, begin to manufacture mature, disease-free blood and immune systems,
thus providing the recipient with a means to permanent recovery. 48
Cord blood stem cell transplants may be performed using blood taken from the
patient himself, a related family member (usually a sibling), or an unknown donor.49
Transplants performed with stem cells taken from one’s own cord blood are known
as autologous cord blood transplants; transplants made by cells donated by a third
party donor are referred to as allogenic transplants.50 Stem cells used in autologous
cord blood transplants provide a perfect match to the child from whom it is taken,
and when used in allogenic transplants, the cells provide a twenty-five percent match
to siblings.51
Although bone marrow donations currently provide the most common source of
hematopoietic stem cells, using cord blood stem cells in transplants has proven to be
just as effective as bone marrow stem cells52 with added advantages.53 Cord blood
stem cells are at the intermediate point between embryonic and adult life and have
high cell proliferation potential.54 Collection of cord blood is painless for both
mother and infant55 and can be done in a matter of minutes,56 whereas bone marrow
donation is both painful and time consuming.57 Unlike bone marrow, which can be

48
Kirschenbaum, supra note 43, at 1394-96. See also Jodi K. Fredrickson, Umbilical Cord
Blood Stem Cells: My Body Makes Them, But Do I Get to Keep Them? Analysis of the FDA
Proposed Regulations and the Impact on Individual Constitutional Property Rights, 14 J.
CONTEMP. HEALTH L. & POL’Y. 477, 484 (1998) (explaining that umbilical cord blood is rich
in stem cells capable of proliferating into the various components of blood, thus serving as a
viable substitute for a traditional bone marrow transplant).
49
See Witte, supra note 1, at 277 (explaining that the cord blood used in transplants can be
obtained from the patient himself or from a third-party donor). See also Kirschenbaum, supra
note 43, at 1394-95 (stating that the patient himself, an identical twin, or a sibling tend to be
the closest match to the recipient, and thus the best source of stem cells).
50
Witte, supra note 1, at 277. See also Fredrickson, supra note 48, at 486 (explaining that
the distinction between autologous and allogenic transplants is that the stem cells used in
autologous transplants are banked for use solely by the donor).
51

Orthner, supra note 1, at 206.

52

Kurtzberg, supra note 4, at 2593. The reported survival rates of cord blood transplant
recipients are similar to those transplanted with matched bone marrow from unrelated donors,
despite the fact that the cord blood was usually slightly mismatched. Id.
53

Witte, supra note 1, at 277. Bone marrow donation procedure entails anesthetizing the
donor, puncturing a bone, usually a hipbone, and drawing out the bone marrow cells with a
syringe. In addition to harvesting long-term, blood-forming stem cells, other cells present in
the donated marrow include stromal cells, stromal stem cells, blood progenitor cells, and
mature and maturing white and red blood cells. NIH, supra note 43.
54
C.P. McGuckin & N. Forraz, Potential for Access to Embryonic-Like Cells from Human
Umbilical Cord Blood, 41 CELL PROLIFERATION 31, 33 (2008).
55

Kirschenbaum, supra note 43, at 1397.

56

Kurtzberg, supra note 4, at 2594.

57
Kirschenbaum, supra note 43, at 1397. See also David A. Suski, Frozen Blood,
Neonates, and FDA: The Regulation of Placental-Umbilical Cord Blood, 84 VA. L. REV. 715,
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harvested from a donor of any age, umbilical cord blood is taken from newborns and
as a result is less likely to contain transmissible infectious diseases, like
cytomegalovirus and Epstein-Barr virus.58 Cord blood stem cells are also more
readily available for transplant.59 With a global rate of about 100 million births per
year, cord blood remains the largest source of available stem cells.60
In addition, when compared to bone marrow, cord blood stem cells demonstrate
better tolerance for slight mismatches between donor and recipient, thus decreasing
the risk of complications.61 The degree to which the donated cord blood stem cells
match, that is, are molecularly similar to, the recipient cells is measured by human
leukocyte antigen (“HLA”) typing.62 Due to their immaturity, cord blood stem cells
are less sensitive to slight HLA mismatches.63 As a result, cord blood is more likely
to engraft,64 and less likely than bone marrow to cause a complication called graftversus-host disease,65 in which donor cells attack host cells and tissue.66

721 (1998) (explaining that one of the drawbacks to use bone marrow rather than umbilical
cord blood in transplantation is that bone marrow transplants are painful for both the donor
and recipient).
58

Mitchell S. Cairo & John E. Wagner, Blood: Placental and/or Umbilical Cord Blood: An
Alternative Source of Hematopoietic Stem Cells for Transplantation, 90 J. AM. SOC’Y
HEMATOLOGY 4665, 4674 (1997). See also Fredrickson, supra note 48, at 484 (stating that
umbilical cord blood stem cells are less likely to contain infectious agents than bone marrow
stem cells taken from an adult donor because the source of cord blood stem cells is an infant
who is less likely to have been exposed to sensitizers or allergens).
59

Kirschenbaum, supra note 43, at 1397. See also Munzer, supra note 47, at 503 (stating
that cord blood is more readily available to unrelated recipients than bone marrow). Because
matches are hard to find, most bone marrow recipients wait anywhere from one month to six
years before finding a matching donor. As a result, many patients deteriorate or die while
waiting for a match to be found. This problem is even more pronounced for non-Caucasian
individuals because they represent a smaller portion of the donor pool and thus have a harder
time finding a matching bone marrow donor. Suski, supra note 57, at 721-22. See also
A.A.P., supra note 42, at 116 (stating that although the number of patients who receive
unrelated donor bone marrow transplants continues to increase each year, five percent of
recipients wait two months for transplantation, fifty percent of recipients wait four months,
and ninety-five percent wait sixteen months. Locating a match among racial and ethnic
minorities is also more difficult because of the limited number of donors. Because patients
could die while waiting for donors, umbilical cord blood provides a life-saving alternative.)
60

McGuckin & Forraz, supra note 54, at 33.

61

Frederickson, supra note 48, at 484.

62

Kirchenbaum, supra note 43, at 1394.

63

McGuckin & Forraz, supra note 54, at 33.

64

Munzer, supra note 47, at 503-04. Engraftment is the process by which the donor’s cells
are accepted by and proliferate into the recipient’s body. Engraftment is crucial because it
helps restore hematopoiesis and the patient’s immune system. Id.
65

Kirschenbaum, supra note 43, at 1394. See also Munzer, supra note 47, at 504
(explaining that cord blood transplants may result in a lower incidence and severity of graftversus-host disease than do bone marrow transplants, even in cord blood transplants with some
HLA mismatch between the donor and recipient). Id.
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Although hematopoietic stem cells harvested from cord blood have several
advantages over bone marrow, one disadvantage of cord blood is that doctors are
only able to extract enough stem cells from the blood for use in transplant for a child;
rarely can enough stem cells be extracted from umbilical cord blood for use in
transplant for an adult.67 Furthermore, cord blood can be donated only once, whereas
a bone marrow donor can produce new marrow and donate again.68 Therefore, while
bone marrow donors can provide multiple transplants for many different individuals,
donation of umbilical cord blood is much more restricted in amount.69
The heightened focus on embryonic stem cells results in a failure to recognize the
potential therapeutic uses of cord blood stem cells.70 Although there is no conclusive
data stating that adult stem cells found in cord blood have as great a potential as
embryonic stem cells, recent studies have shown that these stem cells are far more
useful than previously believed.71 In some studies, cord blood has been shown to
“transdifferentiate to a limited extent into nonhematopoietic cells, including those of
the brain, heart, liver, pancreas, bone, and cartilage.”72 After discovering an
embryonic-like capability of some umbilical cord blood stem cells to differentiate
into a greater number of cells than originally thought, some researchers hypothesize
that some primitive stem cell groups from embryonic development are able to remain
in cord blood.73 After discovering these cells, which are referred to as cord bloodderived embryonic-like stem cells, some scientists suggest a potential use of these
cord blood cells to establish stem cell lines with embryonic properties.74 Although
purely speculative at this point, these studies suggest the possibility that cord blood
may serve, in the future, as a source of cells to facilitate tissue repair and

66

Kirschenbaum, supra note 43, at 1394. Graft-versus-host disease does not occur in
transplants done with cells taken from an identical twin or in autologous transplants. Id.
67
NIH, supra note 43. Initially, cord blood transplantation was restricted to use in
children, usually weighing less than 40 kilograms. Kurtzberg, supra note 4, at 2593. It was
believed that the limited number of cells available from a single unit of umbilical cord blood
was thought to represent only five percent of the optimal dose required for adult
transplantations. McGuckin & Forraz, supra note 54, at 34. More recently, however, use of
cord blood has been extended to include adults. Kurtzberg, supra note 4, at 2593. However,
the problem has not been completely alleviated; the majority of recipients of cord blood stem
cell transplants have still been on the small side, weighing less than 70 kilograms.
Fredrickson, supra note 48, at 485.
68

Munzer, supra note 47, at 504.

69

Id.

70

See also McGuckin & Forraz, supra note 54, at 31 (stating that “all too often media
attention clouds the reality that there are many types of stem cells” and that, despite the strong
emphasis placed on embryonic stem cells, adult stem cells found in bone marrow and
umbilical cord blood are of the types of stem cells with current successful clinical use).
71

Torrisi, supra note 6, at 160.

72

Kurtzberg, supra note 4, at 2596.

73

McGuckin & Forraz, supra note 54, at 34.

74

Id. at 34-37.
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regeneration in a way previously thought to be possible only with embryonic stem
cells.75
III. UMBILICAL CORD BLOOD STEM CELLS: COLLECTION AND STORAGE
Collection of cord blood from the placenta is relatively simple and is usually part
of routine obstetric practice.76 After delivery of the infant, umbilical cord blood,
which is usually discarded, can be collected from the placenta while it is still in utero
or after it has been delivered.77 In order to harvest the stem cells, a needle attached
to a collection bag punctures the umbilical vein and the bag is placed below the
placenta, allowing the blood to flow from the placenta through the cord and into the
bag.78 Usually between 70 and 80 cubic centimeters of cord blood is collected;
however, any amount between 40 and 200 cubic centimeters is sufficient for
banking.79 After the blood is collected, samples are taken for HLA-typing, cell
counts, and other testing.80 An anticoagulant and a cryopreservative are then added
and the sample is stored under liquid nitrogen.81 The cord blood must then be
received by the collection center within twenty-two hours.82 The entire donation
procedure, which poses no physical risk to the mother or baby, can be completed in
about nine or ten minutes.83
Parents may donate umbilical cord blood to public banks for public use or to
private banks for use by the donating family.84 Women delivering healthy babies at
term may donate umbilical cord blood to a public bank, which is then available to the
public for use.85 Donations to public banks increase the likelihood that a potential
75

Kurtzberg, supra note 4, at 2596.

76

Witte, supra note 1, at 276.

77

Fredrickson, supra note 48, at 483, 486. The timing of umbilical cord clamping after
delivery of the infant is important to cord blood donation. Because transplants with greater
amounts of stem cells tend to be more successful, donations with greater volumes of blood are
desired. This could encourage health care personnel to attempt to harvest more cord blood by
clamping the umbilical cord earlier after birth. Immediate clamping after birth would increase
the volume of placental blood for banking; however, if clamping is done too soon after birth,
the infant may be deprived of a placental blood transfusion, resulting in lower blood volume
and increased risk for anemia later in life. Practicing immediate cord clamping as a means to
increase the volume of cord blood available for banking is unethical and should be strongly
discouraged. A.A.P., supra note 42, at 116-17.
78

Kurtzberg, supra note 4, at 2594. The average amount of blood collected is between 70
and 80 cubic centimeters; however, any amount between 40 and 200 cubic centimeters is
sufficient for banking. Fredrickson, supra note 48, at 487.
79

Fredrickson, supra note 48, at 487.

80

Id. at 486-87.

81

Id. at 487.

82

Id.

83

Kurtzberg, supra note 4, at 2594.

84

Orthner, supra note 1, at 206.

85

Kurtzberg, supra note 4, at 2595.
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transplant recipient will find a match from an unrelated donor.86 On the other hand,
parents who donate to a private bank preserve the umbilical cord blood for sole use
by their family. This procedure ensures that, if later in life someone within the
family needs a stem cell transplant, cells are available.87
In spite of the high likelihood of match, because it is unlikely that someone
within the family will actually need the privately banked stem cells, physicians
recommend public banking, rather than private.88 The risk factors indicating a
possible need for future stem cell use within a family, thus justifying private
banking, include a sibling with cancer, a hemoglobinopathy, marrow failure,
congenital immunodeficiency syndrome, or inborn error of metabolism.89 However,
only about one in 20,000 families have risk factors for genetic diseases that may
require a stem cell transplant90 and there is only a one in 10,000 chance that the
infant donor will later require a transplant.91 Furthermore, while donation to a public
86

Orthner, supra note 1, at 206.

87
Kirschenbaum, supra note 43, at 1392. Concerns about exploitation have arisen in
response to aggressive advertising done by private cord blood banks. Advertisements, for
example, promise “peace of mind and a powerful medicinal resource to treat many severe
illnesses for your child and loved ones,” and thus play on the fears of new parents wanting to
provide every advantage for their newborn child. Advertisements may be inaccurate or
misleading, referencing rare, yet-to-be-tested applications of cord blood donations. Kurtzberg,
supra note 4, at 2595. See also Fredrickson, supra note 48, at 483 (explaining that premature
commercialization and solicitation of families provided the impetus for the FDA’s decision to
regulate cord blood stem cells). In addressing the problematic nature of these practices, the
American Academy of Pediatrics points out that families may be vulnerable to emotional
marketing at the time of birth of a child and may look to their physicians for advice. The
Academy encourages cord blood banks, both public and private, to develop recruitment
practices with an awareness of the possible emotional vulnerability of pregnant women and
their families and friends, and recommends that efforts be made to minimize the effect of this
vulnerability on recruitment decisions. A.A.P., supra note 42, at 116-17.
88
Witte, supra note 1, at 277-78. Since the establishment of the first umbilical cord blood
banks, tension between public and private banks has existed. In Europe, official opinion is for
public and against private cord blood banking. Citing the lack of corroboration for any
therapeutic usefulness of autologous transplants provided by commercial banking, the French
National Ethics Committee took the position that decision makers should encourage the
growth and support of public cord blood banks in order to facilitate allogenic transplants. Italy
has gone a step further, making commercial cord blood banking illegal. Jennifer Gunning,
Umbilical Cord Cell Banking: An Issue of Self-Interest versus Altruism, 26 MED. & L. 769,
779-80 (2007). However, in spite of the fact that donors are encouraged to participate in
public banking, in the United States, private banks are more widely used. Torrisi, supra note
6, at 161.
89

Kurtzberg, supra note 4, at 2595.

90

Orthner, supra note 1, at 212. The vast majority of families who participate in private
banking do so for future use in treating degenerative diseases or problems related to injuries or
aging, even though there is no evidence that use of the stem cells will be feasible in such
circumstances. Kurtzberg, supra note 4, at 2595.
91
Orthner, supra note 1, at 212. Estimates regarding the likelihood of children needing
their own stored cells vary. The American Academy of Pediatrics explains that the range of
current estimates is anywhere from 1:1,000 to 1:200,000. The Academy explains that because
evidence that children will need their own stem cells for future use is lacking and because
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bank is usually free of charge, private banking can be quite expensive.92 Private
banking typically requires an initial storage fee of $1,000-1,500 and a $100 annual
storage fee.93 As a result, absent conditions that indicate a future need for sibling
cord blood transplantation, private banking is discouraged and public banking is
recommended.94
Different organizations manage and network the different public cord blood
donations.95 For example, the National Marrow Donor Program (“NMDP”), which is
the largest public banking network in the United States,96 manages a registry listing

there is limited or no evidence regarding the safety or effectiveness of autologous cord blood
transplantation in treating certain conditions, it is not recommended that parents store a child’s
cord blood for future use by that child. A.A.P., supra note 42, at 116.
92

Id. at 206.

93

Kurtzberg, supra note 4, at 2595. StemCyte Family cord blood services, a private bank,
charges an initial $1,925, which covers enrollment, collection, shipping, processing, freezing,
and the storage fee for the first year. For each year of storage thereafter, StemCyte charges
$125, from when the infant turns one year old and continuing until he or she is eighteen.
Orthner, supra note 1, at 206.
94
A.A.P., supra note 42, at 117. It has been suggested by some that the United States
should follow certain European banking services and create dual private and public cord
banks. A dual bank, like Europe’s Virgin Health Group, would retain a certain percentage of
the donated cord blood stem cells for private use, and then designate the remaining cells for
public use. This type of banking would expand the opportunity for research of umbilical cord
blood stem cells because researchers would have access to cells that otherwise would have
been reserved solely for private use. Torrisi, supra note 6, at 161-62.
95

As of 2005, there were approximately 14 public cord blood banks in the United States
and 30 more worldwide. Kurtzberg, supra note 4, at 2595. In the UK, a public bank called
the National Blood Service Cord Bank currently stores over 7,000 cord blood units. In the
United States, the National Marrow Donor Program manages a tremendous public registry.
On the global front, the Bone Marrow Donors Worldwide registry collects data from 38 cord
blood registries from 21 countries and facilitates access to over 200,000 cord blood units
worldwide, from both public and private banks. McGuckin & Forraz, supra note 54, at 33. In
spite of these voluminous numbers, however, all public banks struggle financially because the
revenues generated from sales of cord blood units are generally not enough to support the
bank’s basic operations. Kurtzberg, supra note 4, at 2595.
96
International Cord Blood Society, Public Cord Banking, http://www.cordblood.org/
cord_blood_donations.htm (last visited December 19, 2007). The NMDP manages a diverse
registry of more than 7 million bone marrow donors and 70,000 cord blood units. National
Marrow Donor Program, Providing Hope, Delivering a Cure, http://www.marrow.org/
ABOUT/Providing_Hope/index.html (last visited September 20, 2008). The NMDP connects
more than 450 centers worldwide, which includes transplant centers, donor centers,
recruitment groups, cord blood banks, collection centers, laboratories, apheresis centers
(hospitals that perform peripheral blood stem cell collections) and repositories (centers that
store samples from donors to enable quick follow-up testing when a donor is identified as a
potential match), in order to make stem cell transplants possible. National Marrow Donor
Program, The NMDP Network of Centers, http://www.marrow.org/ABOUT/Providing_Hope/
NMDP_Network/index.html (last visited September 20, 2008).
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the public banks that are part of the National Marrow Donor Program Network.97
The registry also lists the cord blood units collected by hospitals participating in the
NMDP or other public banking networks, thereby making those units available to
any patient in need of transplant.98 However, only certain hospitals are aligned with
a public bank and therefore it is not possible to donate cord blood at every hospital.99
If the hospital participates in cord blood donation, then women interested in donation
must contact the cord blood bank that works with her hospital to start the donation
process.100 If the patient’s hospital does not participate in donation, then the only
other option available to the patient is to find another bank in her area that accepts
cord blood for public donation.101 Furthermore, the availability of public banks and
hospitals that collect donations for those public cord banks varies from state to
state.102 For example, in Ohio only one hospital located in Columbus provides
donation services.103
IV. HISTORY OF CORD BLOOD TRANSPLANTS AND THE CURRENT DEMAND FOR
DONATIONS
Umbilical cord blood has been used in stem cell transplants for treatment of a
variety of diseases since the 1980’s. The first successful transplantation of cord
blood was performed in Paris in 1988 on a 6-year-old boy from North Carolina.104
The patient, who was suffering from Fanconi’s Anemia,105 received a transplant of
umbilical cord blood from his baby sister, fully reconstituting his blood, bone
marrow, and immune system with the donor cells.106 In 1991, the first public cord
97
National Marrow Donor Program, Where to Donate Cord Blood,
http://www.marrow.org/HELP/Donate_Cord_Blood_Share_Life/How_to_Donate_Cord_Bloo
d/CB_Participating_Hospitals/nmdp_cord_blood_hospitals.pl (last visited January 15, 2008).
98

Id.

99

Id.

100

Id.

101

Id. The patient may also be able to donate umbilical cord blood through Cryobanks
International, which accepts donations from anywhere in the continental United States to be
listed on the NMDP Registry. However, Cryobanks International has its own requirements
and eligibility process, and the interested patient must contact Cryobanks to determine if
donation would be feasible. Id. The patient can also inquire as to whether her hospital accepts
cord blood donations for research purposes, rather than for use in future stem cell transplants.
Id.
102

Id.

103

Id. There truly is a wide range in availability of donation services throughout the
United States. For example, in Georgia, Massachusetts, Ohio, and Utah, only one hospital
participates in cord blood donations, whereas in Florida there are nine hospitals, in Illinois, 48,
in Missouri, nineteen, in New York, 20, and in New Jersey, 28. Id.
104

Kurtzberg, supra note 4, at 2592.

105

Id. Classic effects of Fanconi’s Anemia include retarded growth, an extra thumb, only
one kidney, and hypospadias. Witte, supra note 1, at 275.
106

Kurtzberg, supra note 4, at 2592. When the patient’s mother became pregnant a second
time, doctors discovered that the baby was an identical HLA match to her brother and
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blood bank in the world was created at the New York Blood Center, and in 1993, the
first unrelated-donor cord blood transplant was performed on a 3-year-old child with
leukemia, using a cord blood unit from that bank.107
In the time between the first unrelated-donor cord blood transplant in 1993, and
2005, there have been more than 6,000 unrelated-donor transplants performed in
more than 150 locations around the world.108 In 2003 alone, nearly 3,000 transplants
were performed.109 This is a significant increase from the nearly 2,000 transplants
performed in 2000 and the 100 transplants in 1995.110 Although these statistics seem
to suggest that cord blood donations and transplants are being performed at a high
rate, the reality is that donations and transplants, as a result of a general lack of
awareness of the option to donate, occur at a rate far below what is necessary for
effective use of this technology.111
V. CURRENT FEDERAL AND STATE LEGISLATION
Federal and state legislatures have proposed and enacted legislation to support
and encourage cord blood donation. In 2005, Congress recognized the need to
support and increase umbilical cord blood donation and enacted the Stem Cell
Therapeutic and Research Act.112 The legislation was enacted to provide “the
[f]ederal support that is necessary…to more fully realize the potential of cord blood
as a source material for stem cell transplantation.”113 Congress recognized that the
inventory of cord blood currently available fell far below the estimated need,114 and
as a result, passed the legislation, which established a national umbilical cord blood
program and called for the collection and maintenance of 150,000 new units of cord

unaffected by the disorder. After delivery of the baby girl, the umbilical cord blood was
preserved, and then 8 months later transplanted into the patient. Five months after
transplantation, the patient, who had normal clinical and laboratory results, was discharged.
Witte, supra note 1, at 275. Although most scientists and physicians were highly skeptical at
the time, doubting that a small amount of cord blood contained enough stem cells to
reconstitute the child’s bone marrow, the treatment was successful, and the child remained
well and durably engrafted with donor cells for years following the procedure. Kurtzberg,
supra note 4, at 2592.
107

Kurtzberg, supra note 4, at 2592.

108

Id. at 2593.

109

Witte, supra note 1, at 278.

110

Id.

111

Much of the legislation dealing with the subject of umbilical cord blood has noted that a
major goal of the legislation is to rectify the discrepancy between the number of cord blood
units available and the need for transplants. See, e.g., S. REP. NO. 109-129, § II (2005).
112

Id.

113

Id. The legislation was also intended to address the lack of consistent standards for
donor identification, collection and storage of cord blood, and provide a single information
system, readily accessible by both patients and providers, designed to facilitate timely
successful identification of matching transplant material. Id.
114

Id.
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blood to be used in transplantation and research.115 Furthermore, Congress
recognized that in order to increase the number of donations, it would be necessary
to provide pregnant women with clear information about cord blood donation to help
them make an informed choice regarding whether to donate.116
Many states have followed the federal government in addressing the need to
encourage cord blood donation by proposing or passing their own legislation.117
California, for example, passed legislation requiring the State Department of Public
Health to develop information about umbilical cord blood donation that is sufficient
to allow a pregnant woman to make an informed decision regarding cord blood
donation.118 However, even though the information is to be made available over the
internet, there is no provision in the California legislation mandating that health care
workers provide patients with information.119 Section (d)(1) of the Code states, “[a]
primary prenatal care provider of a woman who is known to be pregnant may, during
the first prenatal visit, provide the information…to the pregnant woman” (emphasis
added); therefore, presumably, the decision to provide the information is at the
discretion of the health care provider.120 While the legislators in California should be
commended for their steps taken to support cord blood donation, the legislation falls
short of what is required. Legislation must require that information be provided to
pregnant women.
Other states have passed or proposed more demanding legislation. Arizona
passed legislation, effective January 1, 2007, which states that any health care
professional that has a patient in her second trimester of pregnancy must inform the
patient of the option to donate umbilical cord blood.121 More specifically, the health
care professional must inform the patient of her options related to cord blood stem
cells, which include discarding the cells, donating the cells to a public bank, storing
the cells in a private family cord blood bank for use by immediate and extended
family members, or storing the cells for family use through a family or sibling donor
115

H.R. 2520, 109th Cong. (2005). See also 42 U.S.C.A. § 274k (West 2007) (stating that
the purpose of the legislation was to increase the number of transplants for recipients suitably
matched to biologically unrelated donors of bone marrow and cord blood).
116

Orthner, supra note 1, at 208.

117

See Ariz. Rev. Stat. Ann. § 32-3212 (2007); Ark. Code Ann. § 20-8-504 (West 2007);
Cal. Health & Safety Code § 123371 (West 2007), amended by 2007 Cal. Legis. Serv. Ch. 517
(S.B. 962) (West); Fla. Stat. Ann. § 381.06015 (West 2007); Ga. Code Ann. § 31-46-3 (West
2007); 20 Ill. Comp. Stat. Ann. 2310/2310-342 (West 2007); Kan. Stat. Ann. § 65-1249
(2006); Md. Code Ann., [Health—Gen] § 19-308.7 (West 2007); Mass. Gen. Laws Ann. ch.
111L § 5 (West 2007); N.M. Stat. Ann. § 24-27-4 (West 2007); N.Y. Pub. Health Law § 4371
(McKinney 2007); N.D. Cent. Code § 23-16-15 (2007); Tenn. Code Ann. § 68-32-105 (West
2007); Tex. Health & Safety Code Ann. § 162 (Vernon 2007); Va. Code Ann. § 32.1-69.3
(West 2007); Wis. Stat. Ann. § 146.343 (West 2007).
118

2007 Cal. Legis. Serv. Ch. 517 (S.B. 962) (West).

119

Id.

120

Id.

121

ARIZ. REV. STAT. ANN. § 32-3212 (2007). The statute does, however, provide an
exemption from the obligation to inform the patient about cord blood donation options if the
information conflicts with the health professional’s bona fide religious beliefs. Id.
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banking program that provides free collection, processing, and storage where there is
medical need.122 Furthermore, the legislation states that if the department of health
services has issued a pamphlet on the subject of cord blood donation, the health
professional must provide the patient with that specific pamphlet.123
The state of Georgia has passed similar legislation requiring that information
about cord blood donation be provided to pregnant patients. Section 31-46-3 of the
Georgia Annotated Code requires health care providers to inform pregnant patients
of the option to donate postnatal tissue and fluids; this includes umbilical cord
blood.124 The information must consist of an explanation of public and private
banking, the medical process involved in collection and storage of donated tissue and
fluids, the uses of such donated material, the benefits and risks involved in banking
the material, and the availability and costs of using public and private cord blood
banks.125 Georgia’s legislation requires the physician to inform the pregnant patient
“of the full range of options for donation of postnatal tissue and fluids no later than
30 days from the commencement of the patient’s third trimester of pregnancy or at
the first consultation between the attending physician or the hospital, whichever is
later…”126
Even though these states have taken steps to encourage distribution of
information, there is no statutory requirement that the opportunity to donate be made
available to each pregnant patient at that specific health care facility. Therefore,
although the legislation has the potential to increase awareness of cord blood
donation opportunities, because there is no assurance that donation services will be
made available to each patient, there is no certainty that if the patient, once informed
of her donation options, wants to donate, she will be able to do so. As a result,
although well intentioned, it is unlikely that these pieces of legislation will increase
donations.
VI. OHIO HOUSE BILL 237
Ohio’s proposed legislation, OH H.B. 237, is similar to the legislation enacted in
California. OH H.B. 237 requires the state department of health to prepare and
distribute written materials to health care providers that contain objective
information about umbilical cord blood banking that is sufficient to allow a pregnant

122

Id.

123

Id. Although the health care professional is required to provide the department of
health services’ pamphlet, if one has been made available, the statute also states that the health
care provider meets the notification requirements of the statute by providing the information
verbally, in writing, or by providing the patient with a publication prepared by the department
of health services. Id.
124
GA. CODE ANN. § 31-46-3 (West 2007). The statute designates the Georgia
Commission for Saving the Cure as responsible for developing a program to educate pregnant
patients about public and private banking of postnatal tissue and fluid. Id.
125
126

Id.

Id. Like the Arizona statute, Georgia’s statute § 31-46-3 also includes an exemption
from the obligation for religious reasons, stating that “this subsection shall not be construed to
require the participation of any physician who objects to the transfusion or transplantation of
blood on the basis of bona fide religious beliefs.” Id.
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woman to make an informed decision regarding whether to donate.127 The legislation
states that the department of health is to encourage health care professionals to
provide pregnant women with the written materials before their third trimester of
pregnancy.128 Like the California legislation, there is no provision within the text
requiring health care practitioners to provide each pregnant woman with the
information.
Furthermore, there is no requirement that donation services be
provided to each pregnant patient at each hospital or health care facility. Without
those requirements, it is unlikely, if enacted, that this piece of legislation will
increase donations.
VII. ORGAN DONATION LAWS
In order to understand how the system of organ donation can serve as a model for
cord blood donation, it is important to review the history of organ donation in the
United States. Just as with cord blood donations, after the first successful organ
transplant in 1954 and the flourishing number of transplant procedures performed
thereafter, it became evident that organ donation under existing legislation was
insufficient to satisfy the demand.129 In response, a model law, called the Uniform
Anatomical Gift Act (“UAGA”) was approved in 1968, and by 1973, it had been
adopted in some form by all fifty states.130 Through the Act, the legislature sought to
encourage individuals to become organ donors, specifically providing that any
person eighteen years of age or older may make a gift, effective upon death, of all or
any part of his or her body, to be used in transplants.131 Because the act sought to
127
H.R. 237, 127th Gen. Assembl., Reg. Sess., (Ohio 2007). The proposed legislation was
introduced in May of 2007 and referred to committee in June of 2007. Id.
128

Id. OH H.B. 237 also requires that the department of health distribute the materials free
of charge. Id.
129

Kurnit, supra note 8, at 410. It was really not until the early 1960’s that physicians
began to be truly successful with organ donation. The development of immunosuppressive
therapies finally allowed doctors to control organ rejection, thus making successful
transplantation possible. Maryellen Liddy, The “New Body Snatchers”: Analyzing the Effect
of Presumed Consent Organ Donation Laws on Privacy, Autonomy, and Liberty, 28 FORDHAM
URB. L. J. 815, 821 (2001).
130

Kathleen S. Andersen & Daniel M. Fox, The Impact of Routine Inquiry Laws on Organ
Donation, 7(5) HEALTH AFF. 65, 67 (1988). By 1968, forty-two states had legislation
regulating organ donation; the National Conference of Commissioners on Uniform State Laws
introduced the UAGA partly in order to deal with the lack of uniformity among the states in
regard to organ donation law. By 1972, every state and the District of Columbia had enacted
some form of the UAGA. Abena Richards, Don’t Take Your Organs to Heaven…Heaven
Knows We Need Them Here: Another Look at the Required Response System, 26 N. ILL. U. L.
REV. 365, 371-72 (2006). In drafting the UAGA, the National Conference of Commissioners
sought to reconcile the many different competing interests associated with organ donation.
These interests included the potential donor’s wishes during his lifetime, the wishes of his
surviving family, the state’s interest in conducting an autopsy in cases of crime or violence to
determine the cause of the death, the need for such an autopsy when private legal rights are
affected by the cause of death, and society’s need for donated organs and tissue for education,
research, therapy, and transplantation purposes. Liddy, supra note 129, at 822.
131
Kurnit, supra note 8, at 410. The UAGA recognized the right of next-of-kin to donate
organs of individuals who had not expressed an unwillingness to do so, but it required the
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encourage and protect voluntarism and individual rights, while at the same time
facilitating and encouraging donation, the UAGA became known as embodying the
concept of “encouraged voluntarism.”132
However, it quickly became apparent that the system of encouraged voluntarism
was insufficient to satisfy the demand for organ donation and that federal action was
necessary.133 In an attempt to raise public awareness and encourage donation,
Congress, in 1984, enacted the National Organ Transplant Act (“NOTA”).134 The
explicit authorization of either the deceased or the family. Id. at 411. The UAGA created a
priority scheme under which those surviving the decedent would be allowed to donate his or
her organs. If there were no available people in the prior class at the time of death, and no
objection made by the decedent during his life or notice of opposition of someone in the same
or prior class, then the following people could consent to donation: (1) a spouse, (2) an adult
son or daughter, (3) either parent, (4) an adult brother or sister, (5) a guardian of the decedent
at the time of his death, and (6) any other person authorized or under obligation to dispose of
the body. The sixth category added an element of presumed consent to the act by allowing
medical examiners, as persons authorized or under obligation to dispose of the body, to release
the decedent’s organs and tissues when surviving family members were not available to
object. This allowed coroners, in some situations, to harvest the organs without receiving any
express permission from either the donor (through records) or his surviving family members.
When the UAGA was modified in 1987, the Conference revised the priority scheme, adding a
category for grandparents of the decedent (which followed the adult brother or sister category
and preceded the guardian category) and eliminated the category for any other authorized
person. In substitution for the authorized person section, the Conference drafters added a
section specifically authorizing a medical examiner, coroner, or other official to “release and
permit the removal of a part from a body within that official’s custody, for transplantation or
therapy,” provided that the official complies with certain safeguards. These included
requirements that an organ procurement facility must first request the body part, the official
must make a reasonable effort to locate the potential donor’s medical records and inform any
family members that would fall into the priority scheme, the official must not know of any
objections by the decedent or priority scheme relatives, and the official must ensure that the
harvesting does not interfere with autopsy or investigation. The Conference drafters intended
for the coroner’s release of organs provision under the revised UAGA be more limited and
restrictive than the earlier authorized person provision. Liddy, supra note 129, at 822-25.
Some states that have adopted the UAGA have modified the priority schemes to include health
care agents, friends, and domestic partners. Several states have chosen not to adopt the
coroner release provision; thus in those states, coroners are not able to remove organs without
a record of the decedent’s consent or family approval. Id. at 827.
132
Kurnit, supra note 8, at 411. There are two primary methods under the UAGA for
making an anatomical gift. One way is by will and the other is by signing a document, like a
drivers’ license or identification card. The latter method requires that the donor sign the
document in the presence of two witnesses, who are also required to sign the document.
Richards, supra note 130, at 372.
133

Kurnit, supra note 8, at 411. See generally Charles J. Dougherty, Commentary: A
Proposal for Ethical Organ Donation, 5(3) HEALTH AFF. 105 (1986) (explaining that the
“voluntary opt in” system for organ donation was inadequate to supply all the organs needed
for transplant, even though transplantable organs existed).
134

Kurnit, supra note 8, at 412. Congress also enacted the National Organ Transplant Act
as an attempt to eliminate the black market for organs. In order to reach this goal and promote
altruistic donations, NOTA criminalized the sale or purchase of organs, imposing a sentence
of up to five years in prison or a $50,000 fine for violation. Richards, supra note 130, at 373.
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Act established a comprehensive organ procurement and transplant network and
encouraged state legislatures to adopt routine inquiry legislation, which would
require hospitals to inform family members of patients of the option to donate.135 In
1986 Congress passed the Omnibus Budget Reconciliation Act (“OBRA”) and
adopted a system of required request, which no longer simply encouraged, but
instead required all hospitals to develop required request protocols.136
Although often generalized under the term “required request,” there are actually
two different approaches to organ donation. “Routine inquiry” requires hospitals to
inform family members of the option to donate, whereas “required request” requires
hospitals to expressly ask the family to consent to donation.137 Although OBRA
superseded state law and required all states to adopt routine inquiry protocols at a
minimum, the Act did not prevent states from adopting the stricter system of
required request.138 As a result, great variation exists among the states as to the
requirements placed upon hospitals and health care workers.139 Some states, like
California, operate under the federally mandated system of routine inquiry, requiring
hospital staff to inform the family of the option to participate in organ donation.140
Other states, like Oregon and New York, have enacted the more demanding required
request laws.141 Eighteen states have adopted routine inquiry legislation and twentysix states and the District of Columbia have passed some version of required request
laws.142
VIII. PROPOSED OHIO LEGISLATION: DISTRIBUTION OF INFORMATION AND
DONATION SERVICES PROVIDED TO EVERY PREGNANT PATIENT
Ohio’s proposed legislation is insufficient. Because Ohio’s legislation fails to
mandate that information regarding cord blood donation be provided to all pregnant
women, and will not realistically increase donation, Ohio legislators should discard
OH H.B. 237 and adopt new legislation. Better legislation for Ohio would require
that the state health department compile information regarding umbilical cord blood
sufficient to allow a pregnant woman to make an informed decision about donation.
More specifically, the information should describe donation opportunities, the effects
and uses of cord blood in transplants, and public and private banking. The
legislation should require not only that the information be made available via the
internet, but also to every hospital, clinic, physician, nurse, midwife, or other health
care provider that has prenatal patients. Most importantly, using required request
135

Kurnit, supra note 8, at 412-13.

136

Andersen & Fox, supra note 130, at 72. Giving greater teeth to OBRA, the Health Care
Financing Administration proposed a rule, effective 1988, which required hospitals to comply
with the 1986 OBRA regulations, and thus comply with routine inquiry laws, in order to retain
their eligibility for Medicare and Medicaid reimbursement. Kurnit, supra note 8, at 417.
137

Kurnit, supra note 8, at 412.

138

Id. at 417.

139

Id. at 413.

140

Id. at 414.

141

Id.

142

Andersen & Fox, supra note 130, at 69.
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organ donation laws as its basis, the legislation should require that all health care
providers provide their pregnant patients with information about cord blood donation
opportunities,143 and that health care facilities align with cord blood banks, making
donation services available at each facility to every pregnant patient.
There are arguments for and against the forced distribution of information by
health care providers. Those who advocate for forced distribution of information
recognize that the nation is suffering from donation shortages and believe that
requiring that information be distributed to all maternity patients will increase cord
blood donations.144 As originally introduced, the California legislation included a
mandate requiring prenatal workers to give information on cord blood donation and
banking to all expectant mothers.145 Those who supported the provision requiring
distribution of information to each pregnant patient recognized that one goal of the
legislation was to allow expectant parents to make an appropriate, informed choice
about whether to donate and how the blood should be stored.146 Relying on estimates
by the Institute of Medicine that cord blood could help treat 11,700 Americans a year
suffering from different diseases, proponents of the original mandate sought to
increase the number of cord blood donations by ensuring that every pregnant woman
is made aware of the opportunity to donate.147 Unless it is certain that each patient is
provided with information, the advocates argued, patients will not be given the
opportunity to make a truly informed decision, and donations will not increase.148
Pregnant women, as a group, recognize that a lack of adequate information about
cord blood donation results in missed donation opportunities. A 2001 Canadian
study showed that of the 443 out of 650 pregnant women who responded, seventy
percent rated their knowledge about cord blood banking as poor or very poor.149
143
The majority of health care providers and blood bank personnel believe that consent to
cord blood donation should be obtained earlier in the pregnancy. Kurtzberg, supra note 4, at
2594. Consent should not be obtained from a patient already in active labor or in other
circumstances where her ability to calmly and rationally make decisions is compromised. Id.
However, because many women in labor enter the hospital interested in cord blood donation
without having given prior consent, some health care centers allow women to sign a “mini”
consent form, allowing collection of cord blood, and then meet with her after delivery to
further educate her about cord blood donation and banking and to obtain fully informed
consent. Id. at 2595. Because all cells collected for blood banking need to be tested for
infectious and hereditary diseases before storage, part of the informed consent process must
also address the issue of what is being tested and how the parents will be informed of
abnormal test results. A.A.P., supra note 42, at 117. The possibility of abnormal test results
strengthens the demand that parental consent must be obtained before collection of cord blood.
Id. The ideal time for obtaining consent is during a prenatal visit, well in advance of the onset
of labor. Id.
144

See CA B. An., S.B. 1555, Sen., 8/24/2006.

145

Orthner, supra note 1, at 214.

146

CA B. An., S. B. 1555, Sen. 8/24/2006.

147

Id.

148

See CA B. An., S. B. 1555, Sen. 8/24/2006.

149

Conrad V. Fernandez et al., Knowledge and Attitudes of Pregnant Women with Regard
to Collection, Testing, and Banking of Cord Blood Stem Cells, CAN. MED. ASS’N. J. 695, 696
(2003). Interestingly, about a quarter of the respondents overestimated the risk of a child
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Most of these women (sixty-eight percent) felt that physicians should convey
information about cord blood donation opportunities to their pregnant patients,150 and
most of the women responded that, had they been properly informed, they would
have donated to a public bank.151 As demonstrated by this study, women who are
informed of the opportunity to donate cord blood generally wish to participate in
donation; however, donation opportunities are missed because patients are unaware
of the option to help others by donating cord blood. Thus, ensuring that all pregnant
women are equipped with adequate information will result in an increased number of
completed donations.
Arguments against forced distribution of information about cord blood donation
are minor and insubstantial. The most significant opposition to the forced
distribution portion of the California legislation came from physicians, who argued
that patients would become overwhelmed with information and that physicians
would become overburdened as a result of all the regulations to which they must
conform.152 Though this concern may be warranted, the harm that would occur as a
result of the failure to convey the information would significantly outweigh any
irritation or burden experienced by the patient or physician as a result of being forced
to receive or convey more information. If the inventory of cord blood available for
transplant continues to fall below the estimated need, individuals suffering from
devastating diseases will be without adequate treatment and potential cures; certainly
that devastating result outweighs any minor inconvenience or burden on physicians
to convey, or patients to receive, more information than already required.
The true strength of the argument that legislation must contain a provision
requiring distribution of information to every maternity patient rests in the use of
current organ donation law as a basis and model for such a requirement. Like cord
blood donation, the system of organ donation originally relied on individuals to
inform themselves of donation options and procedures and express a desire to
donate.153 Under that system, for donation to occur, the burden was placed on the
needing a bone marrow transplant before his or her tenth birthday. (The current risk is between
1 in 200,000 and 1 in 10,000.) Id. This data may help demonstrate the existing
misconceptions about the likelihood of future need for stem cells by the donor’s own family.
Those misconceptions, as a result, may tend to motivate some families to participate in private
banking even when they lack the genetic factors that indicate a possible future need. See
Torrisi, supra note 6, at 161 (stating that private banks are more widely used in the United
States than are public banks).
150

Fernandez, supra note 149, at 696. The women wanted to receive information about
cord blood donation and banking either directly from a health care professional (sixty-six
percent), or in a prenatal class (seventy percent). Most of the respondents thought that
pregnant patients should be asked about umbilical cord blood banking before 30 weeks of
pregnancy. Id.
151
Id. at 697. The two main reasons why the women would donate to a public, rather than
private, bank were simple altruism and the expense associated with private banking. Id.
152
Orthner, supra note 1, at 214. In opposing the California legislation, Kaiser Permanente
wrote that it believed the legislation constituted an “unwarranted mandate on clinical
practice.” Furthermore, Kaiser stated that the value of cord blood banking as a preventative
measure had yet to be proven and also cited concerns regarding physician liability. CA B.
An., S. B. 1555, Sen. 8/24/2006.
153

See Kurnit, supra note 8, at 411.
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decedent, who had to have expressed desire to donate during his or her lifetime, or
on his family, who had to consent at the time of death;154 there was no requirement
on health care workers to provide information or access to donation services.155
Although the system of encouraged voluntarism sought to eliminate the need to rely
on purely voluntary action by a potential donor during his lifetime, in practice
physicians rarely proceeded with the removal absent familial consent.156 As a result,
even if the deceased had expressly agreed to donate during his or her life, if, at his or
her death, the family objected to organ donation, it was unlikely that the physician
would proceed with donation, thus adding a further barrier to organ donation.157
In the parallel system of cord blood donation, there is no requirement that health
care providers distribute information to prenatal patients unless the individual state
has legislatively enacted such a provision.158 In order to ensure that donations will
occur when the patient desires, she must already possess knowledge of donation
options and must express these desires to her health care worker. In both systems,
heavy burdens are placed on the individual wishing to donate and it is unlikely,
based on the nature of those burdens, that donations will occur.
The insufficient laws of both the encouraged voluntarism system of organ
donation and the current system in cord blood donation have led to significant
discrepancies between the amount of donations performed and the actual need.
Within the encouraged voluntarism system of organ donation, even in situations
where family members of the potential donor were willing to donate, transplantable
organs were often wasted because there was no request made for donation.159
Similarly, when an expecting mother, who would normally be willing to donate her
child’s umbilical cord blood, is not informed of her option to donate to a bank, the
opportunity to donate is missed.160 Because donation does not occur, the valuable
umbilical cord blood is discarded, thereby diminishing the number of potential
transplants. In order to alleviate this problem, organ donation law changed, adopting
the system of routine inquiry; the system of cord blood donation, encountering
similar problems, should change in similar fashion, adopting requirements of forced
distribution of information.

154

Id. at 410.

155

It was not until 1986, when Congress passed the Omnibus Budget Reconciliation Act,
requiring hospitals and other health care facilities to develop routine inquiry protocols, that
hospital workers were specifically required to inform surviving family members of the option
to donate their loved one’s tissues and organs. Andersen & Fox, supra note 130, at 72.
156

Kurnit, supra note 8, at 411.

157

Id. This facet of encouraged voluntarism helps demonstrate some of the limitations of
the system and the manner in which the system eventually proved insufficient to supply the
number of organs needed for transplants.
158
The federal legislation encourages cord blood donation but does not require that
information regarding donation be provided to pregnant women. Thus, it is up to the state to
mandate such a requirement. 42 U.S.C.A. § 274k (West 2007).
159

Richards, supra note 130, at 376.

160

See Fernandez, supra note 149, at 697.
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Although the results of the transition to a system of required request in organ
donation law is far from clear or conclusive, several states experienced an increase in
donations shortly after adopting required request protocols. This would suggest that
a similar change in cord blood donation law could yield similar results. For
example, one year after passing its required request laws, New York experienced an
increase in heart donations by 94 percent, liver donations by 96 percent, kidney
donations by 23 percent, and eye donations by 58 percent.161 Following
implementation of required request laws, the state of Oregon experienced a 20-25
percent increase in bone and skin donations and a 50 percent increase in eye
donations.162
There are overwhelming similarities between the systems of organ donation and
umbilical cord blood donation. As a result, it is likely that adopting legislation that
requires distribution of information and availability of donation services to patients
in a manner similar to the way family members are informed of donation
opportunities through required request will cause a similar increase in cord blood
donations.
Although other systems, including routine inquiry and presumed consent, exist as
options for current organ donation law, the system of required request best serves as
a model for a more adequate cord blood donation law. Under a system of routine
inquiry, health care providers are required to simply inform the family of its
opportunity to donate organs.163 Like the system of required request, routine inquiry
is an “opt in” system.164 Either the donor or surviving family must authorize
donation; consent is not presumed.165 Although similar to required request, under a
system of routine inquiry there is no requirement that the family be specifically
asked to consent to organ donation.166
Since the system of routing inquiry would not ensure that each patient would be
given the opportunity to donate, the system is insufficient as a model for cord blood
donation. Routine inquiry, which requires that hospital personnel inform individuals
of the opportunity to donate, would ensure that patients are aware of cord blood
donation, but would not ensure that each patient have the opportunity, at each health
care facility, to donate if she desires to do so. Because legislation that ensures
distribution of information to each patient but does not provide for donation services
at each health care institution will not adequately increase cord blood donations,
legislation modeled after routine inquiry organ donation laws would be insufficient.
On the other hand, under a system of presumed consent, a person is presumed,
upon death, to be a donor, unless he or she expressed opposition to donation during
his or her life.167 These systems are known as “opt out” systems because in order to
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Andersen & Fox, supra note 130, at 68-69, 75.

162

Id.
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Kurnit, supra note 8, at 412.

164

Id. at 418.
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Id.

166

See Id. at 412.
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Richards, supra note 130, at 378. In a pure system of presumed consent organ
donation, only the decedent can opt-out of the system during his lifetime; the wishes of the
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prevent donation, potential donors or their families must make an expression of
dissent.168 There are two versions of presumed consent systems used by certain
states within the U.S.169 A softer version requires a search for next of kin of the
deceased, whereas the strict system, first introduced in Maryland, does not.170 The
Maryland Estates and Trust Code provides that a medical examiner is permitted to
remove the deceased’s organs as long as the medical examiner is not aware of
objection made by the next of kin or religious objection made by the decedent before
death.171 The medical examiner is not required to search for an objection and may
remove the organs as long as he is not aware of any such objections.172
Although twenty-eight states have adopted presumed consent systems, only nine
states actively use the laws.173 At least twenty-five nations around the world have
surviving family are not sought nor are they an appropriate basis for the hospital to refrain
from harvesting the potential donor’s organs. In less strict systems of presumed consent,
family members may object to donation, but their wishes will not be actively sought out.
However, in these less strict versions of presumed consent, health care workers may not
proceed with removal if they are aware of an objection by the decedent or the surviving family
members. Kurnit, supra note 8, at 419. Furthermore, in some presumed consent systems,
people may be automatically exempted on the basis of religion. Richards, supra note 130, at
378.
168

Kurnit, supra note 8, at 418. Presumed consent systems are based on the belief that
while most people wish to donate their organs, they are reluctant to address issues regarding
death and organ donation while they are still healthy. Thus a system is required that allows
the state to act upon this silent consensus and remove organs without express permission, and,
as a result, increase the number of organs available for donation. Liddy, supra note 129, at
819. Furthermore, while a presumed consent system requires popular support, it also requires
a well-educated and motivated public. Because individuals must expressly state their refusal
to donate while still legally competent, if the public is uneducated about the system, then
organs will be recovered based upon people’s ignorance, rather than their true desires. In that
situation, the underlying support for the system breaks down, and potential donors are not
provided adequate protection. Consequently, having an effective presumed consent system
requires that mechanisms for recording and reviewing opt-outs or dissents, like a centralized
data bank or registry, be firmly in place. Id. at 819-20.
169

Richards, supra note 130, at 392.

170

Id.

171

Id.

172

Id.

173

Id. Some states have modified their organ donation laws to deal with the extent to
which a coroner may, upon the decedent’s death, remove certain body parts or tissues. These
modifications of organ donation law are known as coroner release statutes. Delaware, Florida,
Georgia, Kentucky, Maryland, Massachusetts, Ohio, and Pennsylvania have adopted coroner
release statutes that allow coroners to remove only the corneas or eyes from decedents based
on presumed consent. Mississippi, on the other hand, allows coroners to harvest the
decedent’s corneas, pituitary glands, and other tissues. These statutes have raised
constitutional concerns about property interests in a dead body, giving rise to a number of
lawsuits. In Georgia Lions Eye Bank, Inc. v. Lavant, 335 S.E.2d 127 (Ga. 1985), the Supreme
Court of Georgia addressed the ramifications of Georgia’s coroner release statute when the
parents of an infant whose corneal tissue was removed during an autopsy filed suit. The
parents were not notified of the removal and thus not given the chance to object to the
procedure; however, the court upheld the statute, holding that removal of the corneal tissue did
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adopted presumed consent, demonstrating the system’s popularity on the
international level.174 In order to alleviate a growing shortage of kidneys for
transplantation, France adopted a system of presumed consent in 1976.175 In June of
1986 Belgium passed a presumed consent law which was implemented in February
1987.176 In 1987 Singapore became the first Asian country to enact presumed
consent legislation.177 Austria operates under a pure system of presumed consent,
refusing surviving family members the opportunity to object to donation of the
deceased’s organs.178 After Austria passed its presumed consent law in 1982, the
donation rate quadrupled and by 1990 the number of performed kidney transplants
was almost equal to those on the waiting list.179 Belgium also experienced donation
increases after changing to a system of presumed consent.180
Presumed consent laws raise ethical concerns within organ donation alone, and
would raise similar concerns in the system of cord blood donation; this makes it an
inappropriate model for proposed legislation. Because in some religions, most
prominently in Islam, the process of organ donation is either restricted or banned
completely, a system that presumes that the deceased wished to participate in organ

not violate the parents’ due process rights, because the quasi-property right of survivors’
interest in a decedent’s body does not rise to the level of constitutional protection. However, a
contrary conclusion was reached in Brotherton v. Cleveland, 173 F.3d 552 (6th Cir. 1999). In
Brotherton, the surviving wife filed suit after her husband’s corneas were removed, as
permitted by Ohio’s limited coroner release statute, during an autopsy. The wife had refused
to donate her husband’s organs when he was pronounced dead; however, the coroner’s office
was not informed of the wife’s objection, and proceeded with the removal. The court
recognized that surviving family members have a substantial interest in the decedent’s body,
and that those property rights rise to the level of a legitimate claim of entitlement under federal
law. The court found for the wife, holding that the Due Process Clause protected her property
interest in her dead husband’s corneas. Liddy, supra note 129, at 828-31.
174

Richards, supra note 130, at 388.

175

Kurnit, supra note 8, at 421.

176
Id. at 422. Belgium established a registry for recording dissents within the presumed
consent system, allowing people to fill out an objection to donation at any local town hall.
The objections are then registered in a centralized database available only to transplant
officials. Physicians, however, are encouraged to discuss organ donation with families, in
spite of the registry, and are not compelled to harvest any organs if they are uncomfortable
doing so. Regardless of this fact, however, the transition in Belgium to presumed consent is
credited with increasing organ donation by fifty-five percent within five years, in spite of the
fact that traffic fatalities, a major source of donated organs, decreased over the same time
period. Because only two percent of Belgians have registered dissents, supporters of
presumed consent infer near-unanimous support for the system within the country. Liddy,
supra note 129, at 820-21.
177

Kurnit, supra note 8, at 424.

178

Id. at 423.

179

BBC Health, Should the UK Change to an Opt-Out System?, http://www.bbc.co.uk/
health/donation/factfilesod_comparisons.shtml (last visited October 27, 2007).
180

Id. Other countries that have adopted presumed consent organ donation laws include
Italy, Norway, Sweden, and Switzerland. Liddy, supra note 129, at 820.
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donation may violate the First Amendment religious freedom of some individuals.181
A presumed consent system may violate the Fifth Amendment, which prohibits
governmental takings of private property without just compensation, if organs are
considered property.182 If defined as property, removal of organs from the deceased
could require the state to provide the family with compensation for donation.183
Although presumed consent systems, on the international level, have encountered
some degree of success in diminishing organ shortages,184 because of the ethical
concerns that arise in presuming one’s consent to organ donation, and because issues
regarding consent already exist in cord blood banking, such a system should not be
applied to cord blood donation law.185 While a minority of banks collect umbilical
cord blood without the mother’s permission and only ask for consent to keep the
cord blood if the procedure was successful, the vast majority of banks operate under
the policy that consent should be obtained prior to collection.186 The American
Academy of Pediatrics supports this position, having expressly rejected the use of a
system of presumed consent in cord blood donation, stating that “[t]he practice of
collecting cord blood first and obtaining permission afterward is considered
unethical and should be discouraged.”187
Despite the ethical and constitutional concerns raised by presumed consent, the
system is gaining more international support. A BBC poll conducted in May 2005
showed that public opinion in the UK regarding presumed consent was changing.188
In 2005, sixty-one percent of those questioned supported a change in UK organ
donation law to an opt out system, which was a substantial increase compared with
the twenty-six percent supporting the change in 1999.189 Those supporting the
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Richards, supra note 130, at 393.

182

Id. at 395.

183

Id.

184

Kurnit, supra note 8, at 442-47. Some countries, however, have not had success with
presumed consent organ donation laws. For example, in February of 1997, the Brazilian
government adopted a presumed consent system, but abolished it only a year later. The
government cited widespread public fear and criticism as the basis for the abolishment. Liddy,
supra note 129, at 821.
185

The system of presumed consent has not been nationally adopted in the United States as
an acceptable system for organ donation law, thus making it an unlikely model for cord blood
donation law. See Richards, supra note 130, at 392.
186

Kurtzberg, supra note 4, at 2594.

187

A.A.P., supra note 42, at 118. See also Cairo & Wagner, supra note 58, at 4673
(stating that consent should not be obtained when the patient is in active labor or immediately
after delivery).
188

BBC Health, supra note 179. When the British Medical Association announced in 1999
that it intended to change its longstanding policy against presumed consent, there was a
significant lack of public support. Intense public debate resulted, with critics labeling the
proposed system as one allowing “body snatching” which would violate the human rights and
dignity of the people. As a result, the government eventually rejected the proposal. Liddy,
supra note 129, at 821.
189

BBC Health, supra note 179.
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change are perhaps responding to the failure of the current opt in system. While
nearly ninety percent of the UK population say they would be willing to donate their
organs after death, only about twenty percent of people have actually put their names
on the NHS Organ Donor Register.190 The British Medical Association, along with
certain patient groups, transplant surgeons, and the Liberal Democrat party support
such a change in the law.191
However, because of the concerns regarding
constitutional violations and consent issues, presumed consent should not be used as
a model for cord blood donation law.
Although the systems of routine inquiry and presumed consent contain
significant elements conducive to increasing the number of completed donations, it is
the system of required request that can serve as the most appropriate model for cord
blood donation law. By rejecting a system of routine inquiry, and instead requiring
that health care providers not only inform patients of the opportunity to donate but
also expressly ask them to consent to donation, which could be performed at that
specific hospital, it becomes much more likely that donations will increase. At the
same time, by rejecting a system of presumed consent, and requiring that consent to
donation be obtained prior to the harvesting of the blood, it is ensured that cord
blood donations will be performed ethically and with respect for both the infant and
maternal donors.
IX. CONCLUSION
Because of the significant therapeutic potential associated with embryonic stem
cells, federal funding of embryonic stem cell research generates great controversy
and attention. However, in focusing solely on human embryos as a source of stem
cells, the public largely ignores the significance of hematopoietic stems cells found
in the umbilical cord blood of newly delivered infants. Although umbilical cord
blood stem cells are currently being used to treat and cure a variety of diseases, a
lack of awareness about cord blood donation results in many missed donation
opportunities. Although legislation has been proposed or adopted by the federal
government and various state governments, including Ohio, as a means to promote
and encourage cord blood donation, it is unlikely that such legislation will be
successful in increasing the number of donations performed because it does not
ensure that all pregnant women are informed. More adequate legislation, modeled
after the required request system of organ donation law, should include a provision
requiring that health care providers provide information and donation services to
each pregnant patient. Legislation will have the potential to increase the number of
donations performed only by ensuring that pregnant women are aware of their
options and have donation services available to them.
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